Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleTheranostics

Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors

Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland and Thomas A. Hope
Journal of Nuclear Medicine February 2021, 62 (2) 221-227; DOI: https://doi.org/10.2967/jnumed.119.241273
Courtney Lawhn-Heath
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Fidelman
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryant Chee
2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salma Jivan
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan Armstrong
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Zhang
3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheila Lindsay
3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily K. Bergsland
2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Hope
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
4Department of Radiology, San Francisco VA Medical Center, San Francisco, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. 2 221-227
DOI 
https://doi.org/10.2967/jnumed.119.241273
PubMed 
32513903

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication January 22, 2020
  • Accepted for publication May 5, 2020
  • Published online January 19, 2021.

Article Versions

  • previous version (June 8, 2020 - 14:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Courtney Lawhn-Heath1,
  2. Nicholas Fidelman1,
  3. Bryant Chee2,
  4. Salma Jivan1,
  5. Evan Armstrong1,
  6. Li Zhang3,
  7. Sheila Lindsay3,
  8. Emily K. Bergsland2,3 and
  9. Thomas A. Hope1,2,4
  1. 1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California
  2. 2Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California
  3. 3Department of Medicine, Division of Medical Oncology, University of California San Francisco, San Francisco, California; and
  4. 4Department of Radiology, San Francisco VA Medical Center, San Francisco, California
  1. For correspondence or reprints contact: Courtney Lawhn-Heath, Department of Radiology and Biomedical Imaging, University of California San Francisco, 505 Parnassus Ave., M-391, San Francisco, CA 94143. E-mail: courtney.lawhnheath{at}ucsf.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 19 Citations
  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
    Thomas A. Hope, Marianne Pavel, Emily K. Bergsland
    Journal of Clinical Oncology 2022 40 24
  • Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
    Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer, Arthur J.A.T. Braat
    Journal of Nuclear Medicine 2022 63 3
  • Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)
    S. C. Ebbers, M. W. Barentsz, D. M. V. de Vries-Huizing, M. W. J. Versleijen, E. G. Klompenhouwer, M. E. T. Tesselaar, M. P. M. Stokkel, T. Brabander, J. Hofland, A. Moelker, R. S. van Leeuwaarde, M. L. J. Smits, A. J. A. T. Braat, M. G. E. H. Lam
    European Journal of Nuclear Medicine and Molecular Imaging 2024 51 4
  • Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
    N.S. Minczeles, J. Hofland, W.W. de Herder, T. Brabander
    Current Oncology Reports 2021 23 4
  • Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy
    Rana Rabei, Nicholas Fidelman
    Current Treatment Options in Oncology 2023 24 12
  • Alpha and Beta Radiation for Theragnostics
    Hong Song, George Sgouros
    PET Clinics 2024 19 3
  • Design and evaluation of 32 P-labeled hydroxyapatite nanoparticles for bone tumor therapy
    Dongliang Zhai, Yumei Wang, Songke Yu, Jiren Zhou, Jia Song, Shilei Hao, Xiaoliang Chen
    Drug Delivery 2023 30 1
  • Radioligand therapies in meningioma: Evidence and future directions
    Maximilian J Mair, Emeline Tabouret, Derek R Johnson, Erik P Sulman, Patrick Y Wen, Matthias Preusser, Nathalie L Albert
    Neuro-Oncology 2024 26 Supplement_9
  • Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine
    HaRam Kim, Boghos Taslakjian, Sarah Kim, Matthew V. Tirrell, Mustafa O. Guler
    ChemBioChem 2024 25 8
  • Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment
    Baizhou Tan, Beiyu Zhang, Hongping Chen
    Frontiers in Endocrinology 2024 15

Article usage

Article usage: June 2020 to April 2025

AbstractFullPdf
Jun 2020513031
Jul 202013509
Aug 2020156031
Sep 2020117016
Oct 202011004
Nov 20205605
Dec 202081023
Jan 20215256167
Feb 20215564050
Mar 20212884834
Apr 20212021020
May 2021166924
Jun 2021125422
Jul 2021943146
Aug 2021393825
Sep 2021336324
Oct 20214216377
Nov 2021345547
Dec 2021203818
Jan 2022362929
Feb 2022282320
Mar 2022214637
Apr 2022114042
May 2022152729
Jun 2022122226
Jul 202293430
Aug 2022102917
Sep 2022112225
Oct 2022112928
Nov 202271911
Dec 2022111713
Jan 202332815
Feb 2023103115
Mar 2023162312
Apr 202382021
May 202392220
Jun 2023132416
Jul 202382116
Aug 2023183319
Sep 2023131415
Oct 202381818
Nov 202393815
Dec 202394716
Jan 202492113
Feb 202491213
Mar 202432122
Apr 202478021
May 202444823
Jun 202472418
Jul 202472821
Aug 202413287
Sep 202472314
Oct 202442615
Nov 202493528
Dec 202423120
Jan 2025144817
Feb 202566824
Mar 202585429
Apr 202586443
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (2)
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland, Thomas A. Hope
Journal of Nuclear Medicine Feb 2021, 62 (2) 221-227; DOI: 10.2967/jnumed.119.241273

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors
Courtney Lawhn-Heath, Nicholas Fidelman, Bryant Chee, Salma Jivan, Evan Armstrong, Li Zhang, Sheila Lindsay, Emily K. Bergsland, Thomas A. Hope
Journal of Nuclear Medicine Feb 2021, 62 (2) 221-227; DOI: 10.2967/jnumed.119.241273
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Highly efficient organ-targeting transport through the ventral midline interstitial channels injection: a new development of interstitium
  • Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  • Google Scholar

More in this TOC Section

Theranostics

  • Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
  • Determination of the Intralesional Distribution of Theranostic 124I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
  • Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
Show more Theranostics

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • gastrointestinal oncology
  • radionuclide therapy
  • liver-directed therapy
  • neuroendocrine tumors
  • somatostatin receptor PET
  • targeted radionuclide therapy
SNMMI

© 2025 SNMMI

Powered by HighWire